Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07101 | 32622088 | Biochim Biophys Acta Mol Cell Biol Lipids | The "discovery" of lipid droplets: A brief history of organelles hidden in plain sight. | 2020 | Details |
| A07102 | 32621970 | Clin Gastroenterol Hepatol | Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease. | 2020 | Details |
| A07103 | 32621944 | J Hepatol | Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. | 2020 | Details |
| A07104 | 32621584 | Endocr Connect | Fighting liver fat. | 2020 | Details |
| A07105 | 32621350 | J Clin Periodontol | Association between periodontal disease, tooth loss and liver diseases risk. | 2020 | Details |
| A07107 | 32621046 | Cardiovasc Drugs Ther | Prolonged-release pirfenidone prevents obesity-induced cardiac steatosis and fibrosis in a mouse NASH model. | 2021 | Details |
| A07108 | 32620763 | Nat Commun | Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. | 2020 | Details |
| A07109 | 32620521 | Dig Liver Dis | Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. | 2020 | Details |
| A07110 | 32619269 | FEBS Lett | SHP-1 ameliorates nonalcoholic steatohepatitis by inhibiting proinflammatory cytokine production. | 2020 | Details |
| A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A07112 | 32618656 | Am J Gastroenterol | Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. | 2020 | Details |
| A07113 | 32618599 | Am J Surg Pathol | Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights. | 2020 | Details |
| A07115 | 32617199 | IEEE J Transl Eng Health Med | Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability. | 2020 | Details |
| A07116 | 32617026 | Hepat Med | Effect of Oral Administration of Weissella confusa on Fecal and Plasma Ethanol Concentrations, Lipids and Glucose Metabolism in Wistar Rats Fed High Fructose and Fat Diet. | 2020 | Details |
| A07117 | 32616276 | Can J Diabetes | Liver Stiffness Is Associated With Progression of Albuminuria in Adults With Type 2 Diabetes: Nonalcoholic Fatty Disease Cohort Study. | 2020 | Details |
| A07118 | 32615709 | Endocrinol Metab (Seoul) | Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07121 | 32614078 | J Food Sci | Relationship between structure and efficacy of sea cucumber saponins echinoside A and its derivatives on hemolytic activity and prevention of nonalcoholic fatty liver disease. | 2020 | Details |
| A07124 | 32613718 | Diabetes Obes Metab | Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial. | 2020 | Details |
| A07125 | 32613381 | Cell Biol Toxicol | Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists. | 2020 | Details |
| A07126 | 32612827 | SAGE Open Med | Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. | 2020 | Details |
| A07127 | 32610455 | J Clin Med | Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07128 | 32610115 | J Hepatol | Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. | 2020 | Details |
| A07129 | 32610095 | Cell Metab | A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. | 2020 | Details |
| A07130 | 32608555 | Microsc Res Tech | Accurate assessment of nonalcoholic fatty liver disease lesions in liver allograft biopsies by a smartphone platform: A proof of concept. | 2020 | Details |
| A07131 | 32608271 | Arch Physiol Biochem | Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone. | 2020 | Details |
| A07132 | 32607889 | Methods Mol Biol | An Obesogenic Dietary Mouse Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07133 | 32607888 | Methods Mol Biol | In Vivo Investigation of High-Fat Diet-Induced Hepatic Lipid Dysfunctions. | 2020 | Details |
| A07134 | 32607879 | Methods Mol Biol | Liver Macrophage Isolation by Flow Cytometry Sorting. | 2020 | Details |
| A07135 | 32607732 | Hepatol Int | Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction. | 2020 | Details |
| A07136 | 32606885 | Clin Exp Gastroenterol | Effects of Aerobic Exercise Protocol on Genes Related to Insulin Resistance and Inflammation in the Pancreas of ob/ob Mice with NAFLD. | 2020 | Details |
| A07137 | 32606872 | Diabetes Metab Syndr Obes | A Linear Relationship Between a Body Shape Index and Risk of Incident Type 2 Diabetes: A Secondary Analysis Based on a Retrospective Cohort Study in Japan. | 2020 | Details |
| A07138 | 32606597 | Drug Des Devel Ther | Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. | 2020 | Details |
| A07139 | 32605646 | Nutr J | Association of the dietary patterns with the risk of non-alcoholic fatty liver disease among Iranian population: a case-control study. | 2020 | Details |
| A07140 | 32605642 | BMC Endocr Disord | Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN). | 2020 | Details |
| A07141 | 32605253 | Cancers (Basel) | Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07142 | 32604760 | Nutrients | Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD. | 2020 | Details |
| A07143 | 32603950 | Atherosclerosis | Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: The Early Vascular Ageing (EVA)-Tyrol Study. | 2020 | Details |
| A07146 | 32603050 | Acta Gastroenterol Belg | Angiogenesis in the progression of non-alcoholic fatty liver disease. | 2020 | Details |
| A07147 | 32603046 | Acta Gastroenterol Belg | A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease. | 2020 | Details |
| A07148 | 32602214 | Hepatol Res | Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan. | 2020 | Details |
| A07149 | 32599713 | Int J Mol Sci | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. | 2020 | Details |
| A07150 | 32599319 | Int Immunopharmacol | Potential anti-inflammatory effect of dapagliflozin in HCHF diet- induced fatty liver degeneration through inhibition of TNF-α, IL-1β, and IL-18 in rat liver. | 2020 | Details |
| A07151 | 32598718 | Ter Arkh | [Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease]. | 2020 | Details |
| A07152 | 32598715 | Ter Arkh | [Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease]. | 2020 | Details |
| A07153 | 32598639 | Ter Arkh | [Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis]. | 2019 | Details |
| A07154 | 32598594 | Ter Arkh | [Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development]. | 2019 | Details |
| A07155 | 32598584 | Ter Arkh | [Peculiarities of heart risk in patients with non - alcoholic fatial liver disease]. | 2019 | Details |
| A07156 | 32598051 | Aliment Pharmacol Ther | Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. | 2020 | Details |
| A07157 | 32597705 | Am J Physiol Gastrointest Liver Physiol | Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease. | 2020 | Details |
| A07158 | 32597296 | Autophagy | The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB. | 2020 | Details |
| A07159 | 32596356 | Biomed Res Int | RANKL Is Involved in Runx2-Triggered Hepatic Infiltration of Macrophages in Mice with NAFLD Induced by a High-Fat Diet. | 2020 | Details |
| A07160 | 32595949 | F1000Res | Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. | 2020 | Details |
| A07161 | 32595752 | Evid Based Complement Alternat Med | Adlay Seed (Coix lacryma-jobi L.) Extracts Exhibit a Prophylactic Effect on Diet-Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in Mice. | 2020 | Details |
| A07162 | 32595436 | Case Rep Gastroenterol | Enoxaparin-Induced Liver Injury. | 2020 | Details |
| A07163 | 32595415 | Cancer Cell Int | LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells. | 2020 | Details |
| A07164 | 32595039 | Biochem Biophys Res Commun | Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK. | 2020 | Details |
| A07165 | 32595023 | Obes Res Clin Pract | Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis. | 2020 | Details |
| A07166 | 32594969 | J Dev Orig Health Dis | Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue. | 2020 | Details |
| A07167 | 32594797 | Hypertension | Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories. | 2020 | Details |
| A07168 | 32594424 | Clin J Gastroenterol | Monitoring chronological change by liver-to-spleen attenuation ratio for secondary hepatic steatosis for a short term. | 2020 | Details |
| A07169 | 32594092 | Med Sci Monit | Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction. | 2020 | Details |
| A07170 | 32593899 | Environ Res | Ferroptosis mediated by the interaction between Mfn2 and IREα promotes arsenic-induced nonalcoholic steatohepatitis. | 2020 | Details |
| A07171 | 32593710 | Life Sci | Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways. | 2020 | Details |
| A07173 | 32592869 | J Neurol Sci | Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers. | 2020 | Details |
| A07174 | 32592770 | Eur J Pharmacol | Hepatoprotective effects of ZLY16, a dual peroxisome proliferator-activated receptor α/δ agonist, in rodent model of nonalcoholic steatohepatitis. | 2020 | Details |
| A07175 | 32592657 | Cell Metab | In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. | 2020 | Details |
| A07176 | 32592532 | Phytother Res | Sophoricoside is a selective LXRβ antagonist with potent therapeutic effects on hepatic steatosis of mice. | 2020 | Details |
| A07179 | 32592194 | Hepatology | iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway. | 2021 | Details |
| A07180 | 32591906 | Pflugers Arch | Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. | 2020 | Details |
| A07181 | 32591883 | Eur Radiol | Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model. | 2020 | Details |
| A07183 | 32591434 | Gut | Loss of hepatic Mboat7 leads to liver fibrosis. | 2020 | Details |
| A07184 | 32590801 | Medicine (Baltimore) | Coronary heart disease is associated with nonalcoholic fatty liver disease in patients without hypertension and diabetes. | 2020 | Details |
| A07185 | 32590752 | Medicine (Baltimore) | Physical activity can reduce the prevalence of gallstone disease among males: An observational study. | 2020 | Details |
| A07187 | 32589269 | Eur J Clin Invest | Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review. | 2020 | Details |
| A07188 | 32589264 | Eur J Clin Invest | COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. | 2020 | Details |
| A07189 | 32588824 | Biomed Khim | [The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs]. | 2020 | Details |
| A07190 | 32588069 | Naunyn Schmiedebergs Arch Pharmacol | In vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti-adipogenic actions. | 2020 | Details |
| A07191 | 32587654 | J Clin Med Res | Associations Between Cannabis Use, Abdominal Fat Phenotypes and Insulin Traits. | 2020 | Details |
| A07192 | 32587515 | Front Pharmacol | Integrated Metagenomic and Metabolomic Analyses of the Effect of Astragalus Polysaccharides on Alleviating High-Fat Diet-Induced Metabolic Disorders. | 2020 | Details |
| A07193 | 32587493 | Saudi J Med Med Sci | Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah. | 2020 | Details |
| A07194 | 32587371 | Sci Rep | Author Correction: A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07195 | 32586479 | Clin Geriatr Med | Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. | 2020 | Details |
| A07196 | 32586422 | Reprod Fertil Dev | Ovulation mitigates fatty liver associated with reproductive suppression and oxidative stress in Damaraland mole-rats (Fukomys damarensis). | 2020 | Details |
| A07197 | 32586350 | BMC Genomics | Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease. | 2020 | Details |
| A07198 | 32585734 | Scand J Med Sci Sports | The impact of high-intensity interval training on inflammatory markers in metabolic disorders: A meta-analysis. | 2020 | Details |
| A07199 | 32585242 | Life Sci | IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease. | 2020 | Details |
| A07200 | 32585136 | Lancet Gastroenterol Hepatol | Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. | 2020 | Details |
| A07201 | 32585065 | Liver Int | Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience. | 2020 | Details |
| A07202 | 32584509 | Cell Biol Int | NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation. | 2020 | Details |
| A07203 | 32583961 | Clin Transl Sci | Evolving Role for Pharmacotherapy in NAFLD/NASH. | 2020 | Details |
| A07204 | 32583938 | Phytother Res | Extract of Schisandra chinensis fruit protects against metabolic dysfunction in high-fat diet induced obese mice via FXR activation. | 2020 | Details |
| A07205 | 32583813 | Am J Case Rep | Cirrhosis in a Young Child Due to Fatty Liver; Importance of Early Screening: A Case Report and Review of the Literature. | 2020 | Details |
| A07206 | 32583511 | Hepatol Res | Liver disease in pregnancy. | 2020 | Details |
| A07207 | 32583444 | J Gastroenterol Hepatol | Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. | 2020 | Details |
| A07208 | 32582754 | Front Nutr | PTEN: A Thrifty Gene That Causes Disease in Times of Plenty? | 2020 | Details |
| A07209 | 32581841 | Front Physiol | Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis. | 2020 | Details |
| A07210 | 32581811 | Front Pharmacol | Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07211 | 32581074 | mSphere | Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity. | 2020 | Details |
| A07212 | 32580141 | EBioMedicine | Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. | 2020 | Details |
| A07213 | 32579995 | Toxicol Lett | Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease. | 2020 | Details |